The over-expression of CD44-ECD induced by Ad-CD44-N-HIF3α4 was clearly observed in immunohistochemical studies (Figure 8), and the anti-tumor activity of Ad-CD44-N-HIF3α4 was significantly greater than Ad-SOCS3 and Ad-p53 (Figure 9). This evidence concerns the gene TP53 and neoplasm.